Family medicine specialists
Bone metabolism experts
Preventive medicine specialists
Internal medicine specialists
Women's health physicians
Geriatric nurse practitioners
Supported by an independent educational grant from Roche Laboratories Inc.
Enrollment for this course is complimentary, and clinicians are invited to attend this CME-certified webcast and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Accreditation Statement for Jointly-Sponsored Programs:
This activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of The University of Massachusetts Medical School
and CMEducation Resources, LLC. The University of Massachusetts Medical School
is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The University of Massachusetts Medical School designates this educational activity
for a maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure:
It is the policy of the University of Massachusetts Medical School to ensure fair
balance, independence, objectivity and scientific rigor in all activities. All
faculty participating in CME activities sponsored by the University of Massachusetts
Medical School are required to present evidence-based data, identify and reference
off-label product use and disclose all relevant financial relationships with those
supporting the activity or others whose products or services are discussed. Faculty
disclosure will be provided in the activity materials.
E. Michael Lewiecki, M.D.
Grant/Research Support: Roche, GSK, Merck, P&G, Amgen, Novartis, Lilly, Wyeth
Consultant: Roche, GSK, Merck, P&G, Amgen, Novartis, Lilly, Wyeth
Speakers Bureau: Roche, GSK, Merck, P&G, Lilly
Stuart L. Silverman, M.D.
Grant/Research Support: Lilly, Merck, Novartis, Wyeth, P&G, Roche
Consultant: Amgen, Roche/GSK, Merck, Wyeth, Lilly, Novartis
Advisory Board: Amgen, Lilly, Merck, Novartis, P&G, Wyeth
Speakers Bureau: Lilly, Roche/GSK, Kyphon, Merck, Novartis, P&G
Mone Zaidi, M.D., PhD, FRCP
Grant/Research Support: P&G
Speakers Bureau: Merck, P&G, Aventis, GSK, Roche
Primary care physicians, internists, family practitioners, osteopathic physicians, nurse practitioners, and specialists will learn to risk stratify patients at risk for osteoporosis and /or related complications, and identify optimal therapeutic approaches.
Primary care physicians, internists, family practitioners, osteopathic physicians, nurse practitioners, and specialists will learn to undertake a systematic evaluation of patients at risk for osteoporosis, including radiological examination and appropriate laboratory markers.
Primary care physicians, internists, family practitioners, osteopathic physicians, nurse practitioners, and specialists will learn evidence-based approaches to reducing progression of osteoporosis and risk of fracture complications.
Clinicians will learn how to select safe and effective pharmacotherapy for prevention and treatment of postmenopausal osteoporosis.
Clinicians will learn how landmark trials and analyses focusing on BMD, bisphosphonate therapy, predictive risk, and fracture reduction should guide clinical management of patients with osteoporosis.
Distinguished Program Faculty and Panel Members
, MD, PhD, FRCP
Professor of Medicine, Geriatrics & Physiology & Biophysics
Mount Sinai School of Medicine
New York, NY
Clinical Assistant Professor of Medicine
University of New Mexico School of Medicine
Clinical Professor of Medicine
Beverly Hills, CA
Copyright (c) 2006 All rights reserved including